Moffitt researchers identify new target to reduce risk of GVHD

(H. Lee Moffitt Cancer Center & Research Institute) Moffitt Cancer Center researchers are trying to identify new drug targets to reduce the risk of GVHD. Their new study, published last week in the Proceedings of the National Academy of Sciences, shows a drug that targets the protein JAK2 may reduce the risk of GVHD.